Biotage AB Statistics

Total Valuation

Biotage AB has a market cap or net worth of SEK 11.32 billion. The enterprise value is 11.14 billion.

Market Cap	11.32B
Enterprise Value	11.14B

Important Dates

The next estimated earnings date is Wednesday, July 16, 2025.

Earnings Date	Jul 16, 2025
Ex-Dividend Date	Apr 25, 2025

Share Statistics

Biotage AB has 80.05 million shares outstanding. The number of shares has increased by 3.44% in one year.

Current Share Class	n/a
Shares Outstanding	80.05M
Shares Change (YoY)	+3.44%
Shares Change (QoQ)	+0.01%
Owned by Insiders (%)	0.94%
Owned by Institutions (%)	60.26%
Float	75.19M

Valuation Ratios

The trailing PE ratio is 44.48 and the forward PE ratio is 47.49. Biotage AB's PEG ratio is 6.78.

PE Ratio	44.48
Forward PE	47.49
PS Ratio	5.77
PB Ratio	2.94
P/TBV Ratio	11.93
P/FCF Ratio	42.87
P/OCF Ratio	32.53
PEG Ratio	6.78

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 23.01, with an EV/FCF ratio of 42.19.

EV / Earnings	43.67
EV / Sales	5.68
EV / EBITDA	23.01
EV / EBIT	33.24
EV / FCF	42.19

Financial Position

The company has a current ratio of 2.53, with a Debt / Equity ratio of 0.06.

Current Ratio	2.53
Quick Ratio	1.53
Debt / Equity	0.06
Debt / EBITDA	0.49
Debt / FCF	0.90
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 6.59% and return on invested capital (ROIC) is 5.09%.

Return on Equity (ROE)	6.59%
Return on Assets (ROA)	4.25%
Return on Invested Capital (ROIC)	5.09%
Return on Capital Employed (ROCE)	7.91%
Revenue Per Employee	3.15M
Profits Per Employee	409,968
Employee Count	680
Asset Turnover	0.40
Inventory Turnover	1.66

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -16.38% in the last 52 weeks. The beta is 0.89, so Biotage AB's price volatility has been lower than the market average.

Beta (5Y)	0.89
52-Week Price Change	-16.38%
50-Day Moving Average	109.66
200-Day Moving Average	152.61
Relative Strength Index (RSI)	77.92
Average Volume (20 Days)	1,181,836

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Biotage AB had revenue of SEK 1.96 billion and earned 255.00 million in profits. Earnings per share was 3.18.

Revenue	1.96B
Gross Profit	1.23B
Operating Income	335.00M
Pretax Income	290.00M
Net Income	255.00M
EBITDA	453.00M
EBIT	335.00M
Earnings Per Share (EPS)	3.18

Full Income Statement

Balance Sheet

The company has 420.00 million in cash and 238.00 million in debt, giving a net cash position of 182.00 million or 2.27 per share.

Cash & Cash Equivalents	420.00M
Total Debt	238.00M
Net Cash	182.00M
Net Cash Per Share	2.27
Equity (Book Value)	3.85B
Book Value Per Share	48.05
Working Capital	729.00M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 348.00 million and capital expenditures -84.00 million, giving a free cash flow of 264.00 million.

Operating Cash Flow	348.00M
Capital Expenditures	-84.00M
Free Cash Flow	264.00M
FCF Per Share	3.30

Full Cash Flow Statement

Margins

Gross margin is 62.62%, with operating and profit margins of 17.08% and 13.00%.

Gross Margin	62.62%
Operating Margin	17.08%
Pretax Margin	14.79%
Profit Margin	13.00%
EBITDA Margin	23.10%
EBIT Margin	17.08%
FCF Margin	13.46%

Dividends & Yields

This stock pays an annual dividend of 1.65, which amounts to a dividend yield of 1.17%.

Dividend Per Share	1.65
Dividend Yield	1.17%
Dividend Growth (YoY)	3.13%
Years of Dividend Growth	n/a
Payout Ratio	50.20%
Buyback Yield	-3.44%
Shareholder Yield	-2.27%
Earnings Yield	2.25%
FCF Yield	2.33%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Biotage AB has an Altman Z-Score of 10.32.

Altman Z-Score	10.32
Piotroski F-Score	n/a